146 related articles for article (PubMed ID: 19614)
21. A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
Cavanagh RL; Usakewicz JJ; Buyniski JP
J Pharmacol Exp Ther; 1983 Jan; 224(1):171-9. PubMed ID: 6129316
[TBL] [Abstract][Full Text] [Related]
22. Characterization and development of cimetidine as a histamine H2-receptor antagonist.
Brimblecombe RW; Duncan WA; Durant GJ; Emmett JC; Ganellin CR; Leslie GB; Parsons ME
Gastroenterology; 1978 Feb; 74(2 Pt 2):339-47. PubMed ID: 23336
[TBL] [Abstract][Full Text] [Related]
23. High-performance liquid chromatographic determination of angiotensin II receptor antagonists in human plasma and urine. I. DuP 532 (L-694,492).
Chiou RH; Lo MW
J Chromatogr; 1992 Oct; 581(1):165-70. PubMed ID: 1430003
[TBL] [Abstract][Full Text] [Related]
24. Tiotidine, a new long-acting histamine H2-receptor antagonist: comparison with cimetidine.
Richardson CT; Feldman M; Brater C; Welborn J
Gastroenterology; 1981 Feb; 80(2):301-6. PubMed ID: 6108895
[TBL] [Abstract][Full Text] [Related]
25. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
[TBL] [Abstract][Full Text] [Related]
26. Determination of famotidine in low-volume human plasma by normal-phase liquid chromatography/tandem mass spectrometry.
Zhong L; Eisenhandler R; Yeh KC
J Mass Spectrom; 2001 Jul; 36(7):736-41. PubMed ID: 11473396
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the solution degradation products of etintidine, an H2-receptor antagonist.
Oyler AR; Naldi RE; Stefanick SM; Lloyd JR; Graden DA; Cotter ML
J Pharm Sci; 1989 Jan; 78(1):21-4. PubMed ID: 2565383
[TBL] [Abstract][Full Text] [Related]
28. Antagonism of vasodepressor and gastric secretory responses to histamine by the H2-receptor antagonists, ranitidine and cimetidine, in the anaesthetized dog.
Daly MJ; Humphray JM; Stables R
Br J Pharmacol; 1981 Jan; 72(1):55-60. PubMed ID: 6112035
[TBL] [Abstract][Full Text] [Related]
29. Simple and universal HPLC-UV method to determine cimetidine, ranitidine, famotidine and nizatidine in urine: application to the analysis of ranitidine and its metabolites in human volunteers.
Ashiru DA; Patel R; Basit AW
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(2):235-40. PubMed ID: 18006395
[TBL] [Abstract][Full Text] [Related]
30. Determination of nizatidine and two of its main metabolites in human serum using high-performance liquid chromatography.
Tracqui A; Kintz P; Mangin P
J Chromatogr; 1990 Aug; 529(2):369-76. PubMed ID: 1977754
[TBL] [Abstract][Full Text] [Related]
31. Determination of roxatidine in human plasma, urine and milk by capillary gas chromatography using nitrogen-selective detection.
Burrows JL; Jolley KW; Sullivan DJ
J Chromatogr; 1988 Nov; 432():199-208. PubMed ID: 2906063
[TBL] [Abstract][Full Text] [Related]
32. High-performance liquid chromatographic measurement of guanidino compounds of clinical importance in human urine and serum by pre-column fluorescence derivatization using benzoin.
Kai M; Miyazaki T; Ohkura Y
J Chromatogr; 1984 Nov; 311(2):257-66. PubMed ID: 6520173
[TBL] [Abstract][Full Text] [Related]
33. Effect of histamine and histamine antagonists on human lower esophageal sphincter function.
Kravitz JJ; Snape WJ; Cohen S
Gastroenterology; 1978 Feb; 74(2 Pt 2):435-40. PubMed ID: 620912
[TBL] [Abstract][Full Text] [Related]
34. Plasma analysis and pharmacokinetics of zaltidine, an H2-antagonist, in cattle after intravenous, intramuscular, subcutaneous, and oral administration.
Hunter RP; Canning PC; Hassfurther R
J Vet Pharmacol Ther; 1996 Aug; 19(4):326-8. PubMed ID: 8866466
[No Abstract] [Full Text] [Related]
35. Liquid chromatographic determination of cimetidine in whole blood and plasma by using short polymeric reverse phase column.
Rustum AM; Hoffman NE
J Assoc Off Anal Chem; 1988; 71(3):519-22. PubMed ID: 3391953
[TBL] [Abstract][Full Text] [Related]
36. Determination of the thromboxane synthetase inhibitor 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (DP-1904) in human plasma and urine using solid-phase extraction and high-performance liquid chromatography.
Tanaka M; Ono K; Takegoshi T
J Chromatogr; 1988 Apr; 426(1):111-9. PubMed ID: 3384863
[TBL] [Abstract][Full Text] [Related]
37. Effect of cimetidine on gastric mucosal histamine and histidine decarboxylase activity in rats.
Masliński S; Sewing KF
Digestion; 1977 Feb; 15(2):121-8. PubMed ID: 14045
[TBL] [Abstract][Full Text] [Related]
38. High-pressure liquid chromatographic determination of cimetidine sulphoxide in human blood and urine.
Lee RM; Osborne PM
J Chromatogr; 1978 Sep; 146(2):354-60. PubMed ID: 701432
[No Abstract] [Full Text] [Related]
39. The use of polymeric solid phase extraction and HPLC analysis for the determination of ranitidine in routine plasma samples obtained from paediatric patients.
Hare LG; Millership JS; Collier PS; McElnay JC; Carson DJ; Shields MS
J Pharm Pharmacol; 2001 Sep; 53(9):1265-72. PubMed ID: 11578109
[TBL] [Abstract][Full Text] [Related]
40. High-performance liquid chromatographic assay for nizatidine, a new H2 blocker, in human plasma and urine using disposable solid-phase extraction columns.
Carlucci G
J Chromatogr; 1990 Feb; 525(2):490-4. PubMed ID: 1970345
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
